Melinda A Pruis

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsPredictive and prognostic markersReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 01, 2023
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.

Melinda A Pruis, Matthew G Krebs, Ruth Plummer

|May 23, 2022
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.

Melinda A Pruis, Floris H Groenendijk, K Sangeeta Badloe

|Jan 07, 2022
Overcoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation.

Melinda A Pruis, M S Paats, W R R Geurts

Pageof 1

Frequent Collaborators

2 joint publications

Anne-Marie C Dingemans

2 joint publications

Martijn P Lolkema

1 joint publications

H J Dubbink

1 joint publications

Debbie Robbrecht